SYNTHIA at AD/PD™ 2025 – Advancing Synthetic Data Innovation for Neurodegenerative Disease Research
We are pleased to announce that SYNTHIA will participate in the upcoming AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, taking place from April 1 - 5, 2025, in Vienna, Austria, and online.
Gates Ventures will represent SYNTHIA to share more about our Alzheimer’s use case, and how synthetic data can drive early detection, personalized care, and responsible AI solutions.
The AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases is the leading global event for neurodegenerative disease research and innovation. This annual scientific meeting brings together global leaders in neurology, neuroscience, and translational medicine to explore the latest advances in research, prevention, and treatment of Alzheimer’s disease, Parkinson’s disease, and related neurodegenerative disorders. What sets this conference apart is its unique focus on the shared mechanisms of these diseases and the opportunity for deep interdisciplinary exchange across clinical and scientific domains.
This year’s theme: Striving for a better future for all those affected by neurodegenerative diseases — perfectly aligned with SYNTHIA’s mission to accelerate breakthroughs in Alzheimer’s through privacy-preserving synthetic data generation (SDG).
